Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics

European Psychiatry

Volumn 16, Issue 6, 2001, Pages 354-361

  Moritz, S ^a   Andresen, B ^a   Jacobsen, D ^a   Mersmann, K ^a   Wilke, U ^a   Lambert, M ^a   Naber, D ^a   Krausz, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Atypical neuroleptics; Disorganization; Negative symptoms; Neuropsychology; Positive symptoms

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SERTINDOLE; ZOTEPINE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PARKINSONISM; POSITIVE AND NEGATIVE AND DISORGANIZED SYMPTOMS SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERBAL COMMUNICATION;

EID: 0034810168     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(01)00591-0     Document Type: Article

References (54)

1. Symptoms of schizophrenia. Methods, meanings, and mechanisms
2. Positive and negative symptoms in schizophrenia
3. Negative vs positive schizophrenia
4. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia
5. Symptomatic and neuropsychological components of defect states
6. Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum
7. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements
8. Syndromes of chronic schizophrenia and some clinical correlates
9. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients
10. The treatment of negative symptoms: Pharmacological and methodological issues
11. Do children and the elderly show heightened semantic priming? How to answer the question
12. Molecular pathology of schizophrenia: More than one dimension of pathology
13. Übersichtstabellen
14. Structure and course of positive and negative symptoms in schizophrenia
15. Three syndromes in schizophrenia: Validity in young patients with recent onset of illness
16. A review of the safety and tolerability of sertindole
17. Dimensionen der schizophrenie im alter. Korrelationen mit kognitiven und motorischen auffälligkeiten
18. An index of factorial simplicity
19. Significance of the positive-negative distinction in schizophrenia
20. The positive and negative syndrome scale (PANSS). Rationale and standardisation
21. Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia
22. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy
23. Schizophrenic syndromes, cognitive performance and neurological dysfunction
24. Volition and schizophrenia
25. Inner connections within domain of dementia praecox: Role of supervisory mental processes in schizophrenia
26. Syndromes of schizophrenia. Classic literature
27. Cerebral blood flow and mental processes in schizophrenia
28. Schizophrenic syndromes and frontal lobe performance
29. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
30. Executive-frontal lobe dysfunction in schizophrenia: A symptom subtype analysis
31. Validity of the negative/positive dichotomy of schizophrenic disorders under long-term conditions
32. Psychopathological syndromes of schizophrenia. Evaluation of the dimensional structure of the Positive and Negative Syndrome Scale (PANSS)
33. The neural correlates of inner speech and auditory verbal imagery in schizophrenia: Relationship to auditory verbal hallucinations
34. The negative component in schizophrenia
35. Further evidence of reduced negative priming in positive schizotypy
36. Neuropsychological correlates of syndromes in schizophrenia
37. Structure of schizophrenic symptomatology and its changes over time: Prospective factor-analytical study
38. Deficit symptoms in schizophrenia: Negative symptoms versus neuroleptic-induced deficits
39. Studies of interference in serial and verbal reactions
40. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidole in the acute treatment of schizophrenia